Clinical Trial News and Research

RSS

Saliva testing offers a non-invasive way to detect early metabolic risk

Measuring elevated levels of insulin in blood, called hyperinsulinemia, is a proven way to measure metabolic health and can show risk of developing future health concerns, including Type 2 diabetes, obesity and heart disease.

31 Jul 2025

Immunoglobulin replacement therapy not associated with reduced risk of serious infections in patients with CLL

In patients with chronic lymphocytic leukemia (CLL), regular treatment with immunoglobulin replacement therapy was not associated with a reduced risk of serious infections requiring hospitalization, according to a study published in Blood Advances.

31 Jul 2025

Artificial sweetener may undermine effectiveness of cancer treatment

Sucralose is a popular sugar substitute for people who are cutting calories or managing blood sugar levels, but new research by the University of Pittsburgh and UPMC Hillman Cancer Center suggests that the artificial sweetener may not be the best choice for patients undergoing cancer immunotherapy.

31 Jul 2025

$29 million grant funds research on fibrinogen in trauma care

The University of Colorado Anschutz Medical Campus will lead a groundbreaking national clinical trial-supported by a $29 million grant from Octapharma-to evaluate whether early replacement of fibrinogen, a critical blood clotting mechanism in the body, can improve outcomes for trauma patients experiencing life-threatening bleeding.

31 Jul 2025

Novel eye-tracking metrics can help properly identify concussion-related vision disorders

In a new study led by Children's Hospital of Philadelphia (CHOP), researchers found that novel eye-tracking metrics can help properly identify concussion-related vision disorders, a common phenomenon among patients with persisting post-concussive symptoms that last more than 28 days after their initial injury.

31 Jul 2025

SimpleSilo offers affordable lifesaving solution for gastroschisis in low-resource settings

In low-resource settings, babies born with gastroschisis - a congenital condition in which the developing intestines extend outside the body through a hole in the abdominal wall -face life-threatening challenges.

30 Jul 2025

Infant brain activity shows faster maturation after general anesthesia

New research published today in Proceedings of the National Academy of Sciences (PNAS) finds that prolonged and/or repeated exposure to gamma-aminobutyric acid (GABA) anesthetic agents (sevoflurane, propofol) for infants in the first two months of life resulted in an accelerated maturation of brain electrical activity patterns evoked by visual stimuli when recorded at 2-5 months of age, compared to infants who did not have early general anesthesia exposure.

30 Jul 2025

Experimental drug found to be safe and effective in treating children with MIS-C

In a small trial, Mass General Brigham researchers found a drug designed to treat Celiac disease supported a more rapid return to normal activities for patients following COVID.

30 Jul 2025

FDA Breakthrough Device designation granted for AI-based mammogram analysis tool

A new technology that harnesses AI to analyze mammograms and improve the accuracy of predicting a woman's personalized five-year risk of developing breast cancer has received Breakthrough Device designation from the Food and Drug Administration (FDA).

30 Jul 2025

Antiviral treatment shows no benefit for early Alzheimer’s patients

The idea that herpes infections trigger or contribute to Alzheimer's disease has been gaining favor among some scientists, raising hope that herpes treatments could slow progression of Alzheimer's symptoms among patients.

30 Jul 2025

Exonate plans 'CLEAR-DE' Phase IIb clinical trial of lead candidate EXN407 for diabetic eye disease

Exonate Ltd., a biotechnology company developing novel, non-invasive, small-molecule therapeutics for patients with retinal vascular diseases, today announced plans to initiate a Phase IIb clinical trial for its lead candidate EXN407.

29 Jul 2025

Self-sampling kits in GP visits boost cervical cancer screening

Women who are overdue for cervical cancer screening are most likely to participate in screening when a self-sampling kit is offered by a healthcare professional as part of routine GP appointments, according to a new study led by Queen Mary University of London with King's College London.

29 Jul 2025

Simple UV technology reduces the number of respiratory infections in aged care facilities

Simple technology that harnesses ultraviolet light to 'zap' airborne viruses has been shown to significantly lower the number of respiratory infections in aged care facilities, paving the way for smarter infection control.

28 Jul 2025

New software predicts cancer cell behavior to advance treatment

In the same vein as weather forecast models that predict developing storms, researchers now have developed a method to predict the cell activity in tissues over time.

28 Jul 2025

Promising new male birth control pill could be taken every three days

YCT-529, a novel non-hormonal male contraceptive, demonstrates safety and tolerability in early trials, offering a potential solution for male birth control.

28 Jul 2025

Study reveals stigmatizing responses in LLMs for addiction-related queries

As artificial intelligence is rapidly developing and becoming a growing presence in healthcare communication, a new study addresses a concern that large language models (LLMs) can reinforce harmful stereotypes by using stigmatizing language.

26 Jul 2025

VCU Massey pioneers clinical trial of novel GGT-1 inhibitor PTX-100

VCU Massey Comprehensive Cancer Center is the first site in the United States to be activated in a global Phase 2a clinical trial evaluating PTX-100 (AKA GGTI-2418), a first-in-class small molecule inhibitor of geranylgeranyl transferase-1 (GGT-1), for the treatment of cutaneous T-cell lymphoma (CTCL), a rare and often treatment-resistant T-cell lymphoma.

26 Jul 2025

Study finds benefits of personalized ventilation in ICU care

A seven-year international, multi-centre clinical trial led by London Health Sciences Centre Research Institute (LHSCRI) and St. Michael's Hospital, a site of Unity Health Toronto, has found that a new ventilation mode called proportional assist ventilation (PAV+™) could improve outcomes for patients in the intensive care unit (ICU) who require help breathing.

24 Jul 2025

Low-dose olanzapine reduces chemo-induced nausea with fewer side effects

Chemotherapy-induced nausea and vomiting are among the most distressing side effects of anti-cancer treatment, particularly for those receiving highly emetogenic regimens such as anthracycline plus cyclophosphamide combinations.

24 Jul 2025

New website empowers women to navigate menopause with confidence

Menopause remains one of the most under-discussed stages of life, even though more than 1 million women in the United States experience this natural biological transition each year.

24 Jul 2025